글로제닉

비상장계속사업자

Glogenic Inc.

박규현

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

글로제닉

Business Reg. No. 1278655973 · CEO 박규현

I.Investment Overview

Target글로제닉 (1278655973)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명글로제닉
영문명Glogenic Inc.
대표자박규현
사업자등록번호1278655973
법인등록번호2802110133434
설립일2014.06.23

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW167.6202034.9202157.9202255.7202327.52024
영업이익100M KRW70.52020-24.720211.32022-2.620234.82024
순이익100M KRW59.32020-27.320211.22022-31202311.82024
Item20242023202220212020
자산총계107.1억원119.2억원154.1억원128.6억원181.3억원
부채총계76억원133.4억원126.3억원121.9억원113.8억원
자본총계31.1억원-14.2억원27.8억원6.6억원67.6억원
매출액27.5억원55.7억원57.9억원34.9억원167.6억원
영업이익4.8억원-2.6억원1.3억원-24.7억원70.5억원
순이익11.8억원-31억원1.2억원-27.3억원59.3억원

VI.Financial Ratios

FY2024 basis

17.34%

영업이익률

42.95%

순이익률

11.02%

ROA

37.93%

ROE

244.21%

부채비율

29.05%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

글로제닉 투심보고서 | Alpha Lenz